Rapid diagnostic tests (RDTs) have played a critical role in the global COVID-19 response, as well as in the management and diagnosis of other diseases, such as malaria and HIV. However, without correct performance of the test and interpretation of the result, the utility of these tests may be compromised, presenting timely and accurate clinical assessment and disease surveillance. 

This Target Product Profile lays out minimal and optimal characteristics for RDT readers to serve as companion tools to support improved test performance, interpretation, and reporting.